Considerations on occupational medical surveillance in employees handling nanoparticles
- 279 Downloads
The use of engineered nanoparticles not only offers new technical perspectives but also raises questions regarding possible health aspects for producers and users. Nanoparticles may, just by virtue of their size, exert biological effects unrelated to the chemicals they are composed of. These considerations, and results from experimental animal studies suggesting that engineered nanomaterials may pose a health hazard to employees, all underscore the need for preventive measures. In this context, the need for, the feasibility, and the appropriateness of targeted occupational medical surveillance are currently subject to debate.
We compared established concepts for the development of occupational medical surveillance programs to existing knowledge on exposures in workplaces and on health effects of nanomaterials.
A variety of potential effect parameters have been proposed for medical surveillance of exposed personnel, such as heart rate variability, blood-clotting parameters, pro-inflammatory cytokines, etc. None of these parameters are specific, most are not validated as individual health risk indicators, and some require sophisticated equipment not routinely available. Against this background, BASF currently puts specific weight on risk assessment and exposure control in workplaces. Particle emissions are primarily avoided by manufacturing in closed systems or using effective extraction systems. Appropriate personal protective equipment has been defined for such operations where an exposure potential cannot be excluded.
While there is presently no evidence-based foundation for “nano-specific” occupational medical screening, one can perform general medical screening with methods targeted at some of the health outcomes under discussion. The results of such examinations can provide a basis for future epidemiologic studies. Therefore, the establishment of exposure registries to enable the conduct of large-scale multi-centric prospective epidemiologic studies is recommended.
KeywordsNanoparticles Occupational medical surveillance Risk assessment
- BASF (2004) Guide to safe manufacture and for activities involving nanoparticles in the workplace. http://corporate.basf.com/en/sustainability/dialog/nanotechnologie/mitarbeiter.htm?id=dipTAAfbhbcp-lj. Last accessed 26 June 2007
- Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, Utell MJ, Huang LS, Cox C, Zareba W, Oberdörster G (2005) Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 171:1129–1135PubMedCrossRefGoogle Scholar
- Blättler MA (1998) Schadstoffexposition beim Schweißen. Sichere Arbeit, pp 25–29Google Scholar
- Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J., Warheit D, Oberdörster E (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3. doi:10.1186/1743-8977-3-11
- Gwinn MR, Vallyathan V (2007) Nanoparticles: health effects—pros and cons. Environ Health Perspect 115:1818–1825Google Scholar
- IARC (1990) Chromium, nickel and welding. In: WHO (ed) IARC monographs on the evaluation of carcinogenic risks to humans, Geneva, vol 49, pp 447–525Google Scholar
- NIOSH, National Institute for Occupational Safety and Health (2007) Progress toward safe nanotechnology in the workplace. DHHS (NIOSH) Publication No. 2007-123Google Scholar
- Scharrer E, Hessel H, Kronseder A, Guth W, Rolinski B, Jörres RA, Radon K, Schierl R, Angerer P, Nowak D (2007) Heart rate variability, hemostatic and acute inflammatory blood parameters in healthy adults after short-term exposure to welding fume. Int Arch Occup Environ Health 80:265–272PubMedCrossRefGoogle Scholar
- Wieners D, Latza U, Baur X (2000) Inhalative Belastungen durch Schweißverfahren. Zbl Arbeitsmed 50:38–44Google Scholar
- Yeatts K, Svendsen E, Creason J, Alexis N, Herbst M, Scott J, Kupper L, Williams R, Neas L, Cascio W, Devlin RB, Peden DB (2007) Coarse particulate matter (PM2.5-10) affects heart rate variability, blood lipids, and circulating eosinophils in adults with asthma. Environ Health Perspect 115:709–714PubMedCrossRefGoogle Scholar
- Zober A (1981) Symptoms and findings at the bronchopulmonary system of electric arc welders. Zbl Bakt Hyg 173:92–119Google Scholar